View all Scholars View all Staff View all Trustees

Tomas J. Philipson

Email
Schedule an Interview

Tomas J. Philipson

More from Tomas J. Philipson

Related Tags
Filter
Content Type
Related Tags
Search More Tags
Article Type
Policies
Projects
Date
Filter
Commentary Health FDA Reform, Pharmaceuticals
Feb 28 2013
FDA Reform Can Lift U.S. Economy
By Tomas J. Philipson Read time 6 mins Read More
Commentary Economics, Public Safety, Health Policing, Crime Control
Mar 19 2012
Demanding Altruism From Drugmakers Won't Improve Health Of Poor
By Paul Howard, Tomas J. Philipson Read time 3 mins Read More
Report Health FDA Reform, Pharmaceuticals
Jun 28 2011
Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research
By Eric Sun, Tomas J. Philipson Read time 6 mins Read More
Podcast Health FDA Reform, Pharmaceuticals
Jun 28 2011
Paul Howard interviews author Tomas Philipson on the institute's latest Project FDA report
Commentary Health FDA Reform, Pharmaceuticals
Jun 14 2010
Quantifying High Cost Of Caution May Speed Drug Approval Process
By Tomas J. Philipson, Eric Sun Read time 5 mins Read More
Report Health FDA Reform, Pharmaceuticals
Jun 12 2010
Cost of Caution: The Impact on Patients of Delayed Drug Approvals
By Eric Sun, Tomas J. Philipson Read time 3 mins Read More
Podcast Health FDA Reform, Pharmaceuticals
Jun 10 2010
Tom Philipson and Eric Sun discuss their new report "Cost of Caution: The Impact on Patients of delayed drug approvals," and how to save lives by streamlining the FDA's drug-development process
Commentary Health
Apr 23 2010
We Can't Lose Our Global Leadership In Medical Innovation
By Tomas J. Philipson Read time 5 mins Read More
Commentary Health
Feb 02 2010
Critical Diagnosis
By Paul Howard, Tomas J. Philipson Read time 4 mins Read More
Commentary Health, Health Pharmaceuticals
Jan 14 2010
The Blue Pill Or The Red Pill?
By Tomas J. Philipson Read time 4 mins Read More